OBJECTIVE: Aberrations in apolipoprotein (apo) metabolism and increased systemic inflammation associate with the metabolic syndrome (MetS) and may contribute to its atherogenicity. We examined whether the association between carotid atherosclerosis and MetS in a population of young adults is mediated by apoB and apoA-I and/or by inflammatory markers C-reactive protein and type II secretory phospholipase A2. METHODS AND RESULTS: We used cross-sectional and 6-year prospective data from the cardiovascular risk in young Finns study. In young adults (aged 24 to 39 years), apoB, C-reactive protein, and type II secretory phospholipase A2 enzyme activity were significantly higher and apoA-I lower in subjects with MetS (N=325) than in subjects without MetS (N=1858). In prospective analysis (N=1587), both MetS and high apoB predicted (P<0.0001) incident high carotid intima-media thickness, defined as carotid intima-media thickness >90th percentile and/or plaque. The association between MetS and incident high carotid intima-media thickness was attenuated by approximately 40% after adjustment with apoB. Adjustments with apoA-I, C-reactive protein, or type II secretory phospholipase A2 did not diminish the association. CONCLUSIONS: High levels of apoB, C-reactive protein, and type II secretory phospholipase A2 and low levels of apoA-I associate with MetS in young adults. The atherogenicity of MetS in this population assessed by incident high carotid intima-media thickness appears to be substantially mediated by elevated apoB but not inflammatory markers.
OBJECTIVE: Aberrations in apolipoprotein (apo) metabolism and increased systemic inflammation associate with the metabolic syndrome (MetS) and may contribute to its atherogenicity. We examined whether the association between carotid atherosclerosis and MetS in a population of young adults is mediated by apoB and apoA-I and/or by inflammatory markers C-reactive protein and type II secretory phospholipase A2. METHODS AND RESULTS: We used cross-sectional and 6-year prospective data from the cardiovascular risk in young Finns study. In young adults (aged 24 to 39 years), apoB, C-reactive protein, and type II secretory phospholipase A2 enzyme activity were significantly higher and apoA-I lower in subjects with MetS (N=325) than in subjects without MetS (N=1858). In prospective analysis (N=1587), both MetS and high apoB predicted (P<0.0001) incident high carotid intima-media thickness, defined as carotid intima-media thickness >90th percentile and/or plaque. The association between MetS and incident high carotid intima-media thickness was attenuated by approximately 40% after adjustment with apoB. Adjustments with apoA-I, C-reactive protein, or type II secretory phospholipase A2 did not diminish the association. CONCLUSIONS: High levels of apoB, C-reactive protein, and type II secretory phospholipase A2 and low levels of apoA-I associate with MetS in young adults. The atherogenicity of MetS in this population assessed by incident high carotid intima-media thickness appears to be substantially mediated by elevated apoB but not inflammatory markers.
Authors: R Colas; A Sassolas; M Guichardant; C Cugnet-Anceau; M Moret; P Moulin; M Lagarde; C Calzada Journal: Diabetologia Date: 2011-08-17 Impact factor: 10.122
Authors: Kristiina S Pälve; Katja Pahkala; Costan G Magnussen; Teemu Koivistoinen; Markus Juonala; Mika Kähönen; Terho Lehtimäki; Tapani Rönnemaa; Jorma S A Viikari; Olli T Raitakari Journal: J Am Heart Assoc Date: 2014-04-22 Impact factor: 5.501
Authors: Frédéric Dutheil; Guillaume Walther; Robert Chapier; George Mnatzaganian; Bruno Lesourd; Geraldine Naughton; Julien Verney; Anne Fogli; Vincent Sapin; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Gérard Lac Journal: Lipids Health Dis Date: 2014-07-11 Impact factor: 3.876
Authors: Di Wang; Markus Juonala; Jorma S A Viikari; Feitong Wu; Nina Hutri-Kähönen; Olli T Raitakari; Costan G Magnussen Journal: J Atheroscler Thromb Date: 2017-07-20 Impact factor: 4.928